Mumbai: Ranbaxy Laboratories shares will stop trading on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) with effect from April 6 as the company is getting merged with Sun Pharmaceutical Industries in a $4-billion deal.
Sun Pharma would be delisting Ranbaxy from the exchanges. It has consummated the merger of Ranbaxy following receipt of requisite approvals.
In separate circulars on Wednesday, BSE and NSE said suspension in trading of the scrip would be effective from "April 6, 2015 (i.e. closing hours of trading on April 1, 2015)".
Sun Pharma has fixed April 7 as the record date for determining the entitlement of Ranbaxy shareholders to the equity shares of the former.
The merger would create India's largest and the world's fifth largest drug maker.